Altogether, these results suggested that the increased expression of GRK2 noted in the breast cancer cell lines and in patients, would also contribute to tumor progression by fostering the cellular mechanisms that induce and stabilize the HIF-1α protein in normoxia. The gene discussed is HIF1A; the disease is breast carcinoma.